A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors - Concepedia

Concepedia

Publication | Closed Access

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

318

Citations

12

References

2003

Year

Bluma Brenner, Dan Turner, Maureen Oliveira, Daniela Moïsi, Mervi Detorio, Mauricio Carobene, Richard Marlink, Jonathan Schapiro, Michel Roger, Mark A. Wainberg

Abstract

V106M may be a signature mutation in clade C patients treated with EFV and may have the potential to confer high-level multi-NNRTI resistance.

References

	Year	Citations

Page 1